Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease. Show reference: <a href= "https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496" target="_blank" rel= "noopener">https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496</a>

Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496

Dr. Jeff Ratliff talks about the FDA approval of Crexont for the treatment of Parkinson disease. Show reference: <a href="https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496" rel="noopener noreferrer">https://jamanetwork.com/journals/jamaneurology/fullarticle/2808496</a>

New Treatment Option for Parkinson Disease

The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.

Share New Treatment Option for Parkinson Disease

Sign up to save your podcasts

New Treatment Option for Parkinson Disease

New Treatment Option for Parkinson Disease

More shows like Neurology Minute

NEJM This Week

JAMA Clinical Reviews

Neurology® Podcast

Practical Neurology Podcast

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

JAMA Neurology Author Interviews

Core IM | Internal Medicine Podcast

Neurology Today in 5

Annals On Call Podcast

JAMA Medical News

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Neurology Exam Prep Podcast

Continuum Audio